EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
5.3.99.5 | furegrelate | - |
Homo sapiens | |
5.3.99.5 | furegrelate | - |
Mus musculus |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
5.3.99.5 | prostaglandin H2 | Mus musculus | - |
thromboxane A2 | - |
? | |
5.3.99.5 | prostaglandin H2 | Homo sapiens | - |
thromboxane A2 | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
5.3.99.5 | Homo sapiens | - |
- |
- |
5.3.99.5 | Mus musculus | - |
- |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
5.3.99.5 | aorta | TXAS is expressed in the atherosclerotic lesion, associated with increased inflammatory cells, in particular M2 polarized macrophages | Mus musculus | - |
5.3.99.5 | aorta | TXAS is expressed in the atherosclerotic lesion, associated with increased inflammatory cells, in particular M2 polarized macrophages | Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
5.3.99.5 | prostaglandin H2 | - |
Mus musculus | thromboxane A2 | - |
? | |
5.3.99.5 | prostaglandin H2 | - |
Homo sapiens | thromboxane A2 | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
5.3.99.5 | thromboxane synthase | - |
Mus musculus |
5.3.99.5 | thromboxane synthase | - |
Homo sapiens |
5.3.99.5 | TXAS | - |
Mus musculus |
5.3.99.5 | TXAS | - |
Homo sapiens |
EC Number | Organism | Comment | Expression |
---|---|---|---|
5.3.99.5 | Mus musculus | inhibition of platelet TXA2 generation (acetylsalicylic acid), lowering of cholesterol (statins), inhibition of platelet aggregation (clopidogrel), or promoting vasodilatation (dipyridamole) has no effect on TXAS mRNA expression levels | additional information |
5.3.99.5 | Homo sapiens | inhibition of platelet TXA2 generation (acetylsalicylic acid), lowering of cholesterol (statins), inhibition of platelet aggregation (clopidogrel), or promoting vasodilatation (dipyridamole) has no effect on TXAS mRNA expression levels | additional information |
5.3.99.5 | Homo sapiens | TXAS increases in atherosclerotic lesions of patients with recent symptoms of thrombotic events | up |
5.3.99.5 | Mus musculus | TXAS mRNA expression is increased within the vascular wall in mouse models of atherosclerosis with advanced lesions | up |